Monopar Therapeutics Inc (MNPR) — Defensive Interval Ratio
Monopar Therapeutics Inc (MNPR) has a Defensive Interval Ratio of 12616 days as of March 2026. Defensive assets of $84.95 Million (cash $-, short-term investments $84.95 Million, receivables $-) cover 12616 days of daily cash needs of $6.73K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Monopar Therapeutics Inc Defensive Interval Ratio (2021–2025)
This chart shows how Monopar Therapeutics Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 12616 days, meaning defensive assets of $84.95 Million can fund 12616 days of operations without new revenue. For the complete balance sheet picture, see Monopar Therapeutics Inc (MNPR) total assets.
Annual Defensive Interval Ratio for Monopar Therapeutics Inc (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Monopar Therapeutics Inc from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital position of Monopar Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 10484 days | $78.57 Million | $7.49K/day | $- | $78.57 Million | ▲ +9484 days |
| 2024 | 1000 days | $14.40 Million | $14.40K/day | $- | $14.40 Million | ▲ +1000 days |
| 2023 | 0 days | $0.00 | $4.81K/day | $- | $0.00 | ▼ -576 days |
| 2022 | 576 days | $4.93 Million | $8.57K/day | $- | $4.93 Million | ▲ +576 days |
| 2021 | 0 days | $0.00 | $4.33K/day | $- | $0.00 | — |